- Passengers who have been vaccinated with two other vaccines, Sinopharm and Sinovac, from China, will be regarded as ‘completely vaccinated’ as of that date.
Following the lead of the US, Canada has stated that persons who have been vaccinated against the coronavirus sickness with Covaxin, an Indian-made vaccine, will be allowed admission (Covid-19).
Travelers who have received the vaccine, made by Bharat Biotech International Limited in Hyderabad, would be regarded as ‘completely vaccinated’ for entry into Canada starting November 30, according to the country’s Public Health Agency (PHAC). “Fully vaccinated individuals with a right of the entrance to Canada who exit and re-enter the nation within 72 hours of leaving Canada will not be required to show a pre-entry molecular test beginning November 30, 2021.”
“This exemption applies only to trips originating in Canada and taken by fully vaccinated Canadian citizens, permanent residents, or individuals registered under the Indian Act,” the health organization said in a statement. “Also, beginning November 30, 2021, Canada will expand the list of Covid-19 vaccines that travelers can receive to be considered fully vaccinated for travel to Canada,” it added.
According to the agency, aside from Covaxin, two other Chinese-made vaccines, Sinopharm and Sinovac, will be recognized on the same date.
The approval is by the World Health Organization’s (WHO) Emergency Use Listing (EUL) for each of the three vaccines; Covaxin received EUL from the WHO on November 3.
Ajay Bisaria, India’s High Commissioner to the North American country, responded to the announcement by tweeting, “Great news for India’s #Covaxin: effective November 30, covid vaccines to be considered fully vaxed for travel to Canada will include Covaxin, matching the @WHO Emergency Use Listing.” Covaxin is India’s first indigenous anti-Covid-19 agent. It has a 77.8 percent efficacy against this viral illness.
Source: Hindustantimes News